Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Post by RisePrize007on Mar 05, 2021 11:14am
101 Views
Post# 32728019

Aion Therapeutic Opens International Center in Jamaica

Aion Therapeutic Opens International Center in Jamaica
 

Aion Therapeutic has announced the opening of the Aion International Center for Psychedelic Psychiatry, a Jamaica-based facility that will specialize in the use of psilocybin in treating addiction, depression, major depressive disorder, and other mental health conditions.

Winston De La Haye, MD, MPH, DM, ICAP, will serve as the center’s medical director. De La Haye is also deputy dean in the Faculty of Medical Sciences at the University of the West Indies in Mona, Jamaica, as well as a consultant general and addiction psychiatrist at University Hospital of the West Indies.

“We need all available and effective products for the treatment of patients with mental illness,” De La Haye said in a news release. “Psychedelic psychiatry has the potential to change the lives of millions of patients, reducing  their disability and improving their quality of life.”

In addition to treating both Jamaican and international patients, the Aion International Center will collaborate with the University of the West Indies and other institutions in Jamaica to research and develop other products to treat patients with mental illness.

source: https://www.psychcongress.com/article/aion-therapeutic-opens-international-center-jamaica


<< Previous
Bullboard Posts
Next >>